Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome reduces effectiveness of hair loss treatment.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Thyroid receptor β can help develop new drugs to treat hair loss.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

New compounds were made that are promising for prostate cancer therapy.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Aromatase inhibitors cause male pattern hair loss in women.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Compound 15a was effective in inhibiting 5α-reductase.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

New compounds may soon be tested to treat excessive hair growth in women.